Nociceptive innervation limits tertiary lymphoid structures to promote lung cancer
Summary
Sensory innervation regulates lung physiology and pathology, but its role in lung cancer is poorly understood. We show that lung adenocarcinoma (LUAD) progression locally amplifies nociceptive sensory innervation and activation, which drives the release of a major sensory neuropeptide, calcitonin gene-related peptide (CGRP). CGRP acts on a subset of macrophages, thereby impairing the recruitment of CXCL13+ fibroblasts and blocking tertiary lymphoid structure (TLS) assembly, a key predictor
Content
# Nociceptive innervation limits tertiary lymphoid structures to promote lung cancer
*Published: 2026 May 19*
Sensory innervation regulates lung physiology and pathology, but its role in
lung cancer is poorly understood. We show that lung adenocarcinoma (LUAD)
progression locally amplifies nociceptive sensory innervation and activation,
which drives the release of a major sensory neuropeptide, calcitonin
gene-related peptide (CGRP). CGRP acts on a subset of macrophages, thereby
impairing the recruitment of CXCL13+ fibroblasts and blocking tertiary lymphoid
structure (TLS) assembly, a key predictor of LUAD prognosis. Local sensory
denervation restores TLS formation, enhances B and T cell-dependent immunity,
and suppresses tumor growth. Cigarette smoke extract (CSE) further activates
this neural circuit to accelerate LUAD progression. In CSE-exposed animals,
pharmacologic CGRP blockade sensitizes tumors to immunotherapy and prolongs
survival. Together, our findings uncover a neuroimmune axis linking nociceptive
neurons, TLS, and LUAD and identify neurogenic inflammation as a mechanism by
which smoking promotes lung tumorigenesis independent of somatic mutagenesis.
DOI: 10.1016/j.cell.2026.04.038